150 related articles for article (PubMed ID: 26998163)
1. Prognostic importance of DNA ploidy in non-endometrioid, high-risk endometrial carcinomas.
Sorbe B
Oncol Lett; 2016 Mar; 11(3):2283-2289. PubMed ID: 26998163
[TBL] [Abstract][Full Text] [Related]
2. Predictive and prognostic factors in definition of risk groups in endometrial carcinoma.
Sorbe B
ISRN Obstet Gynecol; 2012; 2012():325790. PubMed ID: 23209924
[TBL] [Abstract][Full Text] [Related]
3. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy status, S-phase fraction, and p53 are not independent prognostic factors for survival in endometrioid endometrial carcinoma FIGO stage I-III.
Svanvik T; Strömberg U; Holmberg E; Marcickiewicz J; Sundfeldt K
Int J Gynecol Cancer; 2019 Feb; 29(2):305-311. PubMed ID: 30636711
[TBL] [Abstract][Full Text] [Related]
5. The relationship between mutant p53 gene, DNA contents and conventional clinicopathological prognostic variables in cases with endometrial carcinoma.
Osmanağaoğlu MA; Kadioğlu S; Osmanağaoğlu S; Bozkaya H; Reis A; Tekelioğlu Y
Eur J Gynaecol Oncol; 2005; 26(1):64-70. PubMed ID: 15755004
[TBL] [Abstract][Full Text] [Related]
6. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation, measured as flow cytometric S-phase fraction, is a strong prognostic indicator in FIGO stage I endometrioid endometrial carcinoma: a population-based study.
Green RW; Engblom S; Baldetorp B; Hartman L; Måsbäck A; Bjurberg M
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1064-73. PubMed ID: 26123703
[TBL] [Abstract][Full Text] [Related]
8. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
9. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
Stefansson IM; Salvesen HB; Immervoll H; Akslen LA
Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
Santala M; Talvensaari-Mattila A
Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
[TBL] [Abstract][Full Text] [Related]
15. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
16. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of inflammatory parameters and nutritional index in clinical stage IVB endometrial carcinomas.
Kiuchi K; Hasegawa K; Ochiai S; Motegi E; Kuno T; Kosaka N; Fukasawa I
J Obstet Gynaecol; 2019 Feb; 39(2):237-241. PubMed ID: 30370797
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
[TBL] [Abstract][Full Text] [Related]
19. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.
Lax SF; Kurman RJ; Pizer ES; Wu L; Ronnett BM
Am J Surg Pathol; 2000 Sep; 24(9):1201-8. PubMed ID: 10976693
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters.
Kapucuoglu N; Bulbul D; Tulunay G; Temel MA
Int J Gynecol Cancer; 2008; 18(4):790-6. PubMed ID: 17892460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
